ArticleFrontiers in pharmacology2020

Impact of Population and Pharmacogenetics Variations on Efavirenz Pharmacokinetics and Immunologic Outcomes During Anti-Tuberculosis Co-Therapy: A Parallel Prospective Cohort Study in Two Sub-Sahara African Populations.

Sabina Mugusi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.